Xiaohong Rose Yang
Article about Xiaohong Rose Yang, a notable cancer researcher
Xiaohong Rose Yang is a prominent cancer researcher known for her work in genetics and epidemiology. She has made significant contributions to the understanding of genetic predisposition to various types of cancer, particularly breast cancer and thyroid cancer.
Early Life and Education[edit | edit source]
Xiaohong Rose Yang was born in China and developed an early interest in the biological sciences. She pursued her undergraduate studies in biology at a prestigious university in China before moving to the United States for her graduate education. Yang earned her Ph.D. in genetics from a leading American university, where she focused on the genetic factors influencing cancer risk.
Career[edit | edit source]
Yang began her career as a researcher at the National Cancer Institute (NCI), where she worked on identifying genetic mutations associated with increased cancer risk. Her research has been instrumental in the discovery of several genetic markers that are now used in genetic testing for cancer susceptibility.
Research Contributions[edit | edit source]
Yang's research has primarily focused on the role of BRCA1 and BRCA2 genes in breast cancer. She has also studied the PTEN gene and its association with Cowden syndrome, a condition that increases the risk of breast and thyroid cancers. Her work has led to a better understanding of how these genetic mutations contribute to cancer development and progression.
Awards and Recognition[edit | edit source]
Throughout her career, Yang has received numerous awards for her contributions to cancer research. She is a recipient of the American Association for Cancer Research (AACR) award for her groundbreaking work in cancer genetics. Her research has been published in several high-impact scientific journals, and she is frequently invited to speak at international conferences.
Impact on Public Health[edit | edit source]
Yang's research has had a significant impact on public health, particularly in the area of cancer prevention and early detection. Her work has informed guidelines for genetic testing and has helped shape public health policies aimed at reducing cancer incidence through early intervention.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
